Tech Company Financing Transactions
BioCritica Funding Round
BioCritica closed a $25 million funding round on 6/30/2011. Investors included Care Capital and NovaQuest.
Transaction Overview
Company Name
Announced On
6/30/2011
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Undisclosed
Investors
Care Capital (Argeris Karabelas)
NovaQuest (Michael Bologna)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
8888 Keystone Crossing 1300
Indianapolis, IN 46240
USA
Indianapolis, IN 46240
USA
Phone
Website
Email Address
Overview
BioCritica was created to bring a dedicated focus and renewed investment to the commercialization and development of several critical care assets from Eli Lilly and Company.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Broecker
Chief Medical Officer
Mark Williams
Chief Operating Officer
Michael Pagnotta
Browse more venture capital transactions:
Prev: 6/30/2011: Otonomy venture capital transaction
Next: 6/30/2011: Spredfast venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs